biotech

From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world
From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world
Endpoints
R&D
John Houston
Big Pharma
biotech
Arvinas
GSK
Bristol-Myers Squibb
Flag link:
The Biotech Rally Isn’t Over Yet
The Biotech Rally Isn’t Over Yet
Barron's
biotech
Flag link:
Why Amgen, Lilly, J&J Are Interested In These Small Biotechs
Why Amgen, Lilly, J&J Are Interested In These Small Biotechs
Investors Business Daily
Amgen
Eli Lilly
JNJ
Exelixis
biotech
Theravance
Bavarian Nordic
Agios
Biohaven Pharmaceuticals
Progenics
Flag link:
3 Biotech Stocks That Have Already Quadrupled in 2017
3 Biotech Stocks That Have Already Quadrupled in 2017
Stat
biotech
Kite Pharma
Sangamo BioSciences
Dynavax Technologies
Flag link:
3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher?
3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher?
Motley Fool
biotech
Insmed
NewLink Genetics
Voyager Therapeutics
ALIS
indoximod/Keytruda
VY-AADC01
Flag link:
Alternative Perspectives On The Biotech M&A Environment
Alternative Perspectives On The Biotech M&A Environment
Forbes
biotech
M&A
R&D
Flag link:
Biotech, pharma chime in over Trump’s move to halt immigration program
Biotech, pharma chime in over Trump’s move to halt immigration program
Drug Delivery Business News
biotech
pharma industry
immigration
Decibel Therapeutics
Ovid Therapeutics
Biogen
DACA
Flag link:
Merck, looking to build on cancer success, buys I-O biotech Rigontec
Merck, looking to build on cancer success, buys I-O biotech Rigontec
Fierce Biotech
Merck
M&A
Rigontec
biotech
Flag link:
OrbiMed lines up $551M gamble on China, India biotech sectors
OrbiMed lines up $551M gamble on China, India biotech sectors
Endpoints
OrbiMed
China
India
biotech
venture capital
Flag link:
ASCO spotlight presaged two more biotech IPOs angling for $215M
ASCO spotlight presaged two more biotech IPOs angling for $215M
Endpoints
ASCO
IPOs
biotech
Deciphera
DCC-2618
Nucana
Acelarin
Flag link:
Biotech: Back In Vogue
Biotech: Back In Vogue
Barron's
biotech
biotech stocks
Gilead Sciences
M&A
Kite Pharma
Flag link:
3 Biotech Stocks That Could Soar in September
3 Biotech Stocks That Could Soar in September
Motley Fool
biotech
fitusiran
Alnylam
PTC Therapeutics
Translarna
Sarepta
Exondys 51
Flag link:
This Biotech Startup Is Using AI To Help Researchers Develop Cures Quicker
This Biotech Startup Is Using AI To Help Researchers Develop Cures Quicker
Forbes
biotech
artificial intelligence
Innoplexus
Flag link:
Biotech M&A barely showing sign of a pulse so far in 2017
Biotech M&A barely showing sign of a pulse so far in 2017
Endpoints
biotech
M&A
Flag link:
Five Reasons Why Biotech Entrepreneurs Absolutely, Positively Need Neil Young, Miles Davis And Liszt
Five Reasons Why Biotech Entrepreneurs Absolutely, Positively Need Neil Young, Miles Davis And Liszt
Forbes
biotech
innovation
creativity
entrepreneurship
Flag link:
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Motley Fool
biotech
M&A
JNJ
Actelion
Takeda
Ariad Pharmaceuticals
Gilead Sciences
Pfizer
Amgen
Flag link:
Biotech Wunderkind Raises $1.1 Billion To Fund Pharma Startups
Biotech Wunderkind Raises $1.1 Billion To Fund Pharma Startups
Forbes
startups
biotech
Roivant
Vivek Ramaswamy
Flag link:
Amgen Remains A Standout Among Biotechs
Amgen Remains A Standout Among Biotechs
Forbes
Amgen
Repatha
biotech
Flag link:
These 3 Biotechs Just Crushed Analyst Expectations
These 3 Biotechs Just Crushed Analyst Expectations
Motley Fool
biotech
earnings
Sarepta Therapeutics
Biogen
Gilead Sciences
Flag link:
Big Pharma veterans at Pfizer, AstraZeneca join the great migration to biotech
Big Pharma veterans at Pfizer, AstraZeneca join the great migration to biotech
Endpoints
Pfizer
AstraZeneca
Big Pharma
biotech
Flag link: